Page 12 - The Next Pandemic: What's to Come?
P. 12
INDEX
Note: Boldface page numbers Carroll, Dennis, 46–48
indicate illustrations. Center for One Health
Research (University of
Adagio Therapeutics, 30 Washington), 51
Alexa (digital assistant), 12 Centers for Disease Control
animal trade, 5–6 and Prevention (CDC), 11,
antibiotics, overuse of, 6 51, 57
antibodies/antibody testing, 25 COVID-19 testing and,
increased role for, 22–24 21–22
monitoring blood supply for, climate change, 4, 5, 44, 52
16–18 Coalition for Epidemic
See also monoclonal Preparedness Innovations
antibodies (CEPI), 31–33, 35, 41
antibody therapy, 26–30 Codex DNA
antigen test, 25–26 (biopharmaceutical
Apple Watch, 12 company), 34
Aronoff, David, 4, 6, 7 contact tracing, 7
artifi cial intelligence (AI), 7, coronaviruses, 4–5
12–13 cough counting, 15–16
tracking symptoms with, COVID-19 infection
14–16 death rate for, 5
AstraZeneca, 28–29 patients with, 33
tracking of, 13
bat(s), 50 See also SARS-CoV-2
as carriers of viruses, 48, 49 COVID-19 pandemic, 7, 8
Benjamin, Georges C., 9 thermal scanning in, 16
Bill & Melinda Gates CureVac (biotech fi rm), 32,
Foundation, 11 33–34
Binah (tech company), 13–14
Biobot Analytics, 18 deaths/death rates, 5
Brew, Joe, 15 collection of data on, 10–11
Brookings Institution, 56–57 dengue fever, 5
Burton, Dennis R., 37 Dzanga-Sangha Special
Reserve (Central African
camelid nanobodies, 27 Republic), 42, 43, 44
58